Study on the Effect of Controlling Hypertriglyceridemia on Islet Β Cell Function and Glucose Metabolism

西琳·玉努斯,叶尔肯·多森拜克

DOI: https://doi.org/10.3321/j.issn:1006-6187.2007.03.002

2007-01-01

Abstract:Objective To explore the effect of controlling hypertriglyceridemia on HOMA-β, HOMA-IR and glucose metabolism. Methods (1) 140 patients with abnormal glucose metabolism were divided into IGT group, and groups of T2DM with increased HOMA-β (T2DM-1) and decreased HOMA-β (T2DM-2). The levels of glucose, TG, free fatty acids (FFAs) and true insulin (TI) were determined, HOMA-IR and HOMA-β were calculated. (2) The IGT group was treated by 0.25 daily of slow-released fenofibrate for 6 months. For DM patients, treatment to reduce glucose was conducted first for 3 months as self control, and followed by treatment adding fenofibrate. Results IGT group after treatment showed lower levels of FFA(0.51±0.18 vs 0.72±0.32 mmol/L), FPG (5.54±0.38 vs 6.52±0.32 mmol/L), FTI (0.85±0.07 vs 0.99±0.08 mU/L) and HOMA-IR (0.23±0.12 vs 0.44±0.10) (all P0.05) and higher level of HOMA-β (1.85±0.05 vs 1.80±0.06, P0.01) as compared with pre-treatment. T2DM-1 group after treatment adding fenofibrate showed lower levels of FFA (0.49±0.14 vs 0.60±0.17 mmol/L), FPG (7.08±0.99 vs 7.58±1.13 mmol/L), FTI(0.83±0.06 vs 0.91±0.08 mU/L), and HOMA-IR (0.31±0.13 vs 0.42±0.14) and higher HOMA-β (1.74±0.13 vs 1.71±0.07) as compared with pure hypoglycemic treatment. T2DM-2 group after fenofibrate-adding treatment showed lower levels of FFA (0.53±0.16 vs 0.65±0.23 mmol/L), FPG (7.31±1.26 vs 7.86±1.59) and HOMA-IR (0.28±0.11 vs 0.40±0.12), and higher levels of HOMA-β (1.45±0.13 vs 1.32±0.12) and FTI (0.69±0.08 vs 0.60±0.08) (all P0.05) as compared with pure hypoglycemic treatment. Conclusions Control of hypertriglyceridemia could reduce insulin resistance, improve β cell function and glucose metabolism.